Core Insights - Medline (MDLN) shares experienced significant first-day gains, rising by one-third as investor sentiment remains highly optimistic about the company's potential in the healthcare sector [1]. Company Overview - Medline is positioned as a major player in the healthcare industry, attracting considerable investor interest due to its growth prospects [1]. Investment Opportunities - The premium service "Value in Corporate Events" offers insights into major corporate events such as earnings reports, M&A, and IPOs, providing actionable investment ideas [2].

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Dive Brief: Dealmaking in health services is poised for a rebound next year as companies improve in quality and use technology — particularly artificial intelligence — to attract buyers, according to a report published Tuesday by PwC. The potential M&A boost in 2026 comes after a slowdown this year. Deal value reached roughly $46 billion through Nov. 30, c ...

Core Insights - HCA Healthcare UK has successfully implemented MEDITECH Expanse across its 11 acute facilities and numerous outpatient locations, which enhances patient safety and improves workflow efficiencies [1] Company Overview - HCA Healthcare UK is a leading private healthcare provider that focuses on delivering high-quality healthcare services [1] Technology Implementation - The MEDITECH Expanse is an innovative, cloud-based electronic health record (EHR) system that provides clinicians with a unified, multi-disciplinary health record [1] - This system allows for a seamless view of the patient's journey and health status, accessible whenever and wherever the patient receives care [1]

Group 1: Company Overview - Medline Inc. shares surged 41.38% during regular trading hours on Wednesday, but declined by 2.47% to $39.99 in after-hours trading [1] - The company priced its upsized initial public offering (IPO) at $29 per share for 216.03 million Class A common shares [1] Group 2: Underwriters and Deal Structure - Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities, and J.P. Morgan served as global coordinators and lead bookrunning managers for the IPO [2] - Other bookrunning managers included Barclays, Citigroup, Deutsche Bank Securities, Jefferies, and UBS Investment Bank [2] Group 3: Use of Proceeds - Medline will use proceeds from 37.03 million shares and any exercise of the underwriters' option to purchase an additional 32.40 million shares to purchase or redeem equity interests from pre-IPO owners [4] - The offering is expected to close on Thursday, subject to customary closing conditions [4] Group 4: Trading Metrics - Medline has a market capitalization of $32.27 billion [5] - The stock closed at $41 on Wednesday, but Benzinga's Edge Stock Rankings indicate a negative price trend across all time frames for MDLN stock [5]

ATLANTA, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (NASDAQ: AVAH) today announced that its management team will attend the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 14, 2026. Management will present at 9:45 a.m. PST followed by 1x1 investor meetings on the same day, January 14, 2026. Interested investors and other parties may also listen to a simultaneous webcast of the presentation by logging onto the Investor Relations section of the Com ...

Turn to Dan Primac. He's the business editor at Axios who brought our attention to the boring IPO boom last week. Dan, um, does it become much more buzzy next year.>> I think so. And I think, as Leslie said, I think you're going to see more of these deals. I mean, it's worth noting Medline was kind of exceptional in private equity terms anyway, right.This was a deal that was done in 2021. It was a return of so-called club deals. I believe it's the largest healthcare leverage buyout ever.Um, so it was a very ...

Core Insights - UnitedHealth Group has demonstrated significant rally potential, with historical gains exceeding 30% in crucial years and over 50% in 2020 and 2025, suggesting future catalysts could lead to exceptional stock performance [2] - Despite a sharp decline from 2024 peaks due to high medical expenses and regulatory changes, UnitedHealth is projected to recover in 2026, presenting an attractive entry point for investors [3] Financial Performance - UnitedHealth's revenue growth and cash generation metrics highlight its strong business fundamentals, although investment risks should be considered during broader market declines [6] - A comparison of UnitedHealth's fundamentals with S&P medians indicates robust financial health, reinforcing its potential for future growth [5] Growth Drivers - Optum is expected to experience accelerated double-digit revenue growth and margin enhancement through strategic investments in value-based care, digital health, and AI innovation [11] - Strategic withdrawals from unprofitable Medicare Advantage plans and responsive pricing for 2026 premiums are anticipated to significantly boost profitability [11] - Positive financial guidance for 2026 could lead to a substantial re-evaluation of UnitedHealth's stock, especially if it indicates a return to double-digit earnings growth [11]

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Ardent Health, Inc. (NYSE: ARDT) for potential violations of the federal securities laws. If you invested in Ardent, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-health-inc-class-action-investigation. Why Is Ardent being Investigated for Securities Violations?Ardent is a provider of healthcare in mid-sized urban communities ...

ORANGE, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 14, at 10:30 a.m. PST A webcast and replay of the presentation will be available on Alignment’s investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and live their m ...

SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLPis investigating potential violations of U.S. federal securities laws involving Ardent Health, Inc. (NYSE: ARDT), focused on whether Ardent Health and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information that could assist in the Ardent Health investigation or if you are an Ardent Health investor who suffered a loss and would like to ...